CEACAM1 and Miyoshi myopathy: We have demonstrated the over expression of CEACAM1 in WM vs. IgM MGUS and vs. CTRLs B-cells, confirming previous investigations which showed the up regulation of CD66a in bone marrow samples of non-Hodgkin lymphoma (NHL) and MM [32].